We have been funding research since 2012. Explore our timeline of research projects below, or browse our Current or Completed project pages.
Gene therapy and Gene editing
Cell therapy
Drug therapy
Protein therapy
EB cancer therapy
Development of an eye treatment for ocular surface damage
Read more
Chemoprevention of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma
Replay next-generation gene therapy for DEB
An opthalmic solution for the treatment of corneal abrasions associated with epidermolysis bullosa
Evaluation of long-term effect on skin homeostasis and regeneration in a RDEB mouse model using different delivery methods of LNPs encapsulating mRNA-based base editing approach
Bespoke antisense oligomer-mediated splice modulating therapies for Recessive Dystrophic Epidermolysis Bullosa patients
Towards cell and gene therapy for Junctional Epidermolysis Bullosa airway disease
Development of NvA-011 for topical application in Dystrophic Epidermolysis Bullosa
Base and prime editing strategies for Recessive Dystrophic Epidermolysis Bullosa
Gene & Cell Therapy in Recessive Dystrophic Epidermolysis Squamous Cell Carcinoma